Robert W Fairbairn

Director

Robert W Fairbairn (Director) filed 4 Form 4 reports in the trailing twelve months (1 purchase, 3 sales), most often in BMEZ. Across 1 priced purchase filing, the average 21-session return was -4.5% from execution and -4.5% from disclosure (delay-adjusted; derived). The largest single filing was $498K of MYN (49,025 sh × $10.15, as filed), executed Feb 27.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

-4.5%

avg across 1 priced filings

Delay-adjustediThe same average, entered at disclosure dates

-4.5%

same 1 filings, from disclosure

Filings, ttm

1 buys · 3 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.2M

shares × price, as filed

Last traded

Feb 27

Filed Mar 3

Open performance→

Volume by month

Buys $498K Sells $661K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Not on file 4 filings

Sector per market data · by filing · past 12 months

Most traded names

BMEZ BMEZ BMEZ · 0 buys · 1 sell 1 filing BSTZ BSTZ BSTZ · 0 buys · 1 sell 1 filing BTX BTX BTX · 0 buys · 1 sell 1 filing MYN MYN MYN · 1 buy · 0 sells 1 filing

Recent filings

MYNPURCHASE BLACKROCK MUNIYIELD NEW YORK QUALITY FUND, INC. View filing → $498K
49,025 sh × $10.15
Exec Feb 27
Filed Mar 3 · 3:15 PM ET BSTZSALE BlackRock Science & Technology Term Trust View filing → $209K
9,293 sh × $22.51
Exec Dec 18 2025
Filed Dec 22 2025 · 5:30 PM ET BTXSALE BlackRock Technology & Private Equity Term Trust View filing → $143K
21,936 sh × $6.52
Exec Dec 18 2025
Filed Dec 22 2025 · 5:30 PM ET BMEZSALE BlackRock Health Sciences Term Trust View filing → $308K
20,588 sh across 2 lots
Exec Dec 18 2025
Filed Dec 22 2025 · 5:30 PM ET